TechBio Founders #16:  Accelerating drug discovery with fully automated robotic  experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris episode artwork

EPISODE · May 5, 2023 · 41 MIN

TechBio Founders #16: Accelerating drug discovery with fully automated robotic experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris

from Next Sequence · host Martin-Immanuel Bittner, Loretta TIOIELA

Arctoris is a tech-enabled drug discovery company headquartered in Oxford and Boston. Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and rapidly progress its wholly owned and partnered drug discovery programs in oncology and neurology.

Episode metadata supplied by the publisher feed · Published May 5, 2023

Embed this episode

NOW PLAYING

TechBio Founders #16: Accelerating drug discovery with fully automated robotic experiment execution and digital data capture with Martin-Immanuel Bittner, CEO Arctoris

0:00 41:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 41 minutes long.

When was this Next Sequence episode published?

This episode was published on May 5, 2023.

Can I download this Next Sequence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!